{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:15:56Z","timestamp":1783743356859,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s13105-022-00914-4","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T03:30:46Z","timestamp":1663903846000},"page":"885-895","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MicroRNA-34b-5p binds enhancer of zeste 2 to inhibit milk fat globule-EGF factor 8 expression, affecting liver fibrosis"],"prefix":"10.1007","volume":"78","author":[{"given":"Jing","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3880-0583","authenticated-orcid":false,"given":"Yongfang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"914_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5152\/tjg.2018.17330","volume":"29","author":"MM Aydin","year":"2018","unstructured":"Aydin MM, Akcali KC (2018) Liver fibrosis. Turk J Gastroenterol 29:14\u201321","journal-title":"Turk J Gastroenterol"},{"issue":"Suppl 1","key":"914_CR2","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1016\/j.clinre.2015.05.005","volume":"39","author":"D Schuppan","year":"2015","unstructured":"Schuppan D (2015) Liver fibrosis: common mechanisms and antifibrotic therapies. Clin Res Hepatol Gastroenterol 39(Suppl 1):S51-59","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"914_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","volume":"121","author":"T Higashi","year":"2017","unstructured":"Higashi T, Friedman SL, Hoshida Y (2017) Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev 121:27\u201342","journal-title":"Adv Drug Deliv Rev"},{"key":"914_CR4","doi-asserted-by":"crossref","unstructured":"Roehlen N, Crouchet E, Baumert TF (2020) Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells 9: 875","DOI":"10.3390\/cells9040875"},{"key":"914_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0036-1597816","volume":"37","author":"L Campana","year":"2017","unstructured":"Campana L, Iredale JP (2017) Regression of liver fibrosis. Semin Liver Dis 37:1\u201310","journal-title":"Semin Liver Dis"},{"key":"914_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5604\/16652681.1226814","volume":"16","author":"A Altamirano-Barrera","year":"2017","unstructured":"Altamirano-Barrera A, Barranco-Fragoso B, Mendez-Sanchez N (2017) Management strategies for liver fibrosis. Ann Hepatol 16:48\u201356","journal-title":"Ann Hepatol"},{"key":"914_CR7","doi-asserted-by":"publisher","first-page":"10993","DOI":"10.1038\/ncomms10993","volume":"7","author":"J Hyun","year":"2016","unstructured":"Hyun J, Wang S, Kim J et al (2016) MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression. Nat Commun 7:10993","journal-title":"Nat Commun"},{"key":"914_CR8","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1038\/mt.2016.127","volume":"24","author":"Y Matsumoto","year":"2016","unstructured":"Matsumoto Y, Itami S, Kuroda M et al (2016) MiR-29a assists in preventing the activation of human stellate cells and promotes recovery from liver fibrosis in mice. Mol Ther 24:1848\u20131859","journal-title":"Mol Ther"},{"key":"914_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.omtn.2017.11.010","volume":"10","author":"L Zhou","year":"2018","unstructured":"Zhou L, Liu S, Han M et al (2018) miR-185 inhibits fibrogenic activation of hepatic stellate cells and prevents liver fibrosis. Mol Ther Nucleic Acids 10:91\u2013102","journal-title":"Mol Ther Nucleic Acids"},{"key":"914_CR10","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1111\/j.1742-4658.2011.08075.x","volume":"278","author":"WQ Li","year":"2011","unstructured":"Li WQ, Chen C, Xu MD et al (2011) The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats. FEBS J 278:1522\u20131532","journal-title":"FEBS J"},{"key":"914_CR11","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1002\/cbin.11022","volume":"42","author":"X Feili","year":"2018","unstructured":"Feili X, Wu S, Ye W, Tu J, Lou L (2018) MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-beta1\/Smad3 pathway in hepatic stellate cells. Cell Biol Int 42:1370\u20131376","journal-title":"Cell Biol Int"},{"key":"914_CR12","first-page":"2273","volume":"23","author":"RP Hu","year":"2019","unstructured":"Hu RP, Lu YY, Zhang XJ (2019) MiR-34b-5p knockdown attenuates bleomycin-induced pulmonary fibrosis by targeting tissue inhibitor of metalloproteinase 3 (TIMP3). Eur Rev Med Pharmacol Sci 23:2273\u20132279","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"914_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1615\/CritRevEukaryotGeneExpr.2019025273","volume":"29","author":"AM Aghdam","year":"2019","unstructured":"Aghdam AM, Amiri A, Salarinia R et al (2019) MicroRNAs as diagnostic, prognostic, and therapeutic biomarkers in prostate cancer. Crit Rev Eukaryot Gene Expr 29:127\u2013139","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"914_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.7150\/thno.46360","volume":"11","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Xiang C, Zhong F et al (2021) Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis. Theranostics 11:361\u2013378","journal-title":"Theranostics"},{"key":"914_CR15","doi-asserted-by":"crossref","unstructured":"Mann J, Chu DC, Maxwell A et al (2010) MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 138:705-14, 714.e1-4","DOI":"10.1053\/j.gastro.2009.10.002"},{"key":"914_CR16","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1053\/j.gastro.2016.12.003","volume":"152","author":"SY An","year":"2017","unstructured":"An SY, Jang YJ, Lim HJ et al (2017) Milk fat globule -EGF factor 8, Secreted by mesenchymal stem cells, protects against liver fibrosis in mice. Gastroenterology 152:1174\u20131186","journal-title":"Gastroenterology"},{"key":"914_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5483\/BMBRep.2017.50.2.012","volume":"50","author":"YJ Jang","year":"2017","unstructured":"Jang YJ, An SY, Kim JH (2017) Identification of MFGE8 in mesenchymal stem cell secretome as an anti-fibrotic factor in liver fibrosis. BMB Rep 50:58\u201359","journal-title":"BMB Rep"},{"key":"914_CR18","doi-asserted-by":"crossref","unstructured":"Li H, Zhang T, Wang K et al (2019) MFGE8 protects against CCl4 -induced liver injury by reducing apoptosis and promoting proliferation of hepatocytes. J Cell Physiol: Online ahead of print","DOI":"10.1002\/jcp.28314"},{"key":"914_CR19","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/cam4.309","volume":"3","author":"T Jinushi","year":"2014","unstructured":"Jinushi T, Shibayama Y, Kinoshita I et al (2014) Low expression levels of microRNA-124-5p correlated with poor prognosis in colorectal cancer via targeting of SMC4. Cancer Med 3:1544\u20131552","journal-title":"Cancer Med"},{"key":"914_CR20","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/jcmm.16119","volume":"25","author":"Z Du","year":"2021","unstructured":"Du Z, Wu T, Liu L, Luo B, Wei C (2021) Extracellular vesicles-derived miR-150-5p secreted by adipose-derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis. J Cell Mol Med 25:701\u2013715","journal-title":"J Cell Mol Med"},{"key":"914_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.lfs.2018.04.008","volume":"202","author":"L Li","year":"2018","unstructured":"Li L, Sun Z, Xu C et al (2018) Adenovirus-mediated overexpression of sST2 attenuates cardiac injury in the rat with severe acute pancreatitis. Life Sci 202:167\u2013174","journal-title":"Life Sci"},{"key":"914_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.hlc.2016.10.009","volume":"26","author":"J Wu","year":"2017","unstructured":"Wu J, Wang J, Li X et al (2017) MicroRNA-145 mediates the formation of angiotensin II-induced murine abdominal aortic aneurysm. Heart Lung Circ 26:619\u2013626","journal-title":"Heart Lung Circ"},{"key":"914_CR23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696\u2013699","journal-title":"J Hepatol"},{"key":"914_CR24","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/jcp.22824","volume":"227","author":"JY Lim","year":"2012","unstructured":"Lim JY, Oh MA, Kim WH, Sohn HY, Park SI (2012) AMP-activated protein kinase inhibits TGF-beta-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300. J Cell Physiol 227:1081\u20131089","journal-title":"J Cell Physiol"},{"key":"914_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/hep.23922","volume":"53","author":"C Roderburg","year":"2011","unstructured":"Roderburg C, Urban GW, Bettermann K et al (2011) Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53:209\u2013218","journal-title":"Hepatology"},{"key":"914_CR26","doi-asserted-by":"publisher","first-page":"G101","DOI":"10.1152\/ajpgi.00220.2009","volume":"298","author":"SK Venugopal","year":"2010","unstructured":"Venugopal SK, Jiang J, Kim TH et al (2010) Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol 298:G101-106","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"914_CR27","doi-asserted-by":"crossref","unstructured":"Dewidar B, Meyer C, Dooley S, Meindl-Beinker AN (2019) TGF-beta in hepatic stellate cell activation and liver fibrogenesis-updated 2019. Cells 8:1419","DOI":"10.3390\/cells8111419"},{"key":"914_CR28","doi-asserted-by":"crossref","unstructured":"Lee S, Woo DC, Kang J et al (2020) The role of the histone methyltransferase EZH2 in liver inflammation and fibrosis in STAM NASH mice. Biology (Basel) 9:93","DOI":"10.3390\/biology9050093"},{"key":"914_CR29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41419-021-03800-x","volume":"12","author":"Y Lu","year":"2021","unstructured":"Lu Y, Liu L, Pan J et al (2021) MFG-E8 regulated by miR-99b-5p protects against osteoarthritis by targeting chondrocyte senescence and macrophage reprogramming via the NF-kappaB pathway. Cell Death Dis 12:533","journal-title":"Cell Death Dis"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-022-00914-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13105-022-00914-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-022-00914-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T12:25:31Z","timestamp":1669206331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13105-022-00914-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["914"],"URL":"https:\/\/doi.org\/10.1007\/s13105-022-00914-4","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"11 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animals were housed per the protocols permitted by the Institutional Animal Care and Use Committee of The Second Xiangya Hospital. All the experimental protocols obtained permission from the Animal Use Ethics Committee of The Second Xiangya Hospital (No. 2021524).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors agreed with the content and all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute\/organization where they work, before the work is submitted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}